ABEO · Abeona Therapeutics Inc
United States · RS rating 12 · As of 2026-10-14
| Price | 4.36 USD |
|---|---|
| 1-day change | -3.5% |
| RS rating (overall / 1M / 3M / 12M) | 12 / 11 / 8 / 27 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 30 / 23 / 17 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -16.7% |
| Sales growth Q/Q | +60.9% |
| Distance from 52-week high | +41.5% |
| Market cap (USD) | $314.9M |